Article Listing - Three new partnerships for Sanofi

OPTIMIZATION OF GLOBAL R&D STRATEGY

20 April 1992

Because pharmaceutical development times contain, of necessity, prescribed periods which are of similar duration for competing innovator companies (eg long-term...

EC PHARMA MARKET LURCHES TO COMPLETION

20 April 1992

The complex issue of creating a unified drug marketing approval regime in the European Comm-unity internal market is outlined in...

MERGER DENIALS BY CIBA-GEIGY

20 April 1992

Alex Krauer, managing director of the Swiss chemical and pharmaceutical concern, Ciba-Geigy, has denied that his company could be about...

SLIGHT RISE IN UCB PRETAX PROFITS

20 April 1992

The Belgian UCB chemical and pharmaceutical group UCB announced a slight rise of 1% in pretax ordinary profits for 1991...

US AIDS MARKET FORECASTS TO 1998

20 April 1992

The US market for products to diagnose, monitor and treat AIDS will grow from close to $300 million in 1991...

US SENATE PASSES DEBARMENT BILL

20 April 1992

The US Senate passed HR 2454, the Generic Drug Enforcement Act, with some amendments, just before Congress broke for the...

DRUG REVIEW PLAN SETS FOUR INITIATIVES

20 April 1992

Four initiatives are to be implemented by the US Food and Drug Administration to speed access to new drugs and...

CELTRIX' THOMAS DAVIS

20 April 1992

Thomas Davis is elected to the board of directors at Celtrix Pharmaceuticals.

CANGENE CANCER DRUG IN TRIALS?

20 April 1992

Canadian biotechnology concern Cangene has applied for permission from the Canadian government to begin clinical testing of leucotropin, the company's...

CHINESE ARTHRITIS REMEDY UNDER TEST

20 April 1992

Researchers at the University of Texas Southwestern Medical Center in the USA have applied to the US Food and Drug...

Showing 94261-94270 of 95353 articles